Zobrazeno 1 - 10
of 210
pro vyhledávání: '"D.S. McMeekin"'
Autor:
Annika Auranen
Publikováno v:
Acta Obstetricia et Gynecologica Scandinavica. 97:899-899
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eab3893950a96b3290a082bac1fdf89d
https://doi.org/10.1111/aogs.13318
https://doi.org/10.1111/aogs.13318
Autor:
Matthew C. MacAllister, Joan L. Walker, Gerald McGwin, D.S. McMeekin, Robert S. Mannel, Elizabeth K. Nugent, Lisa M. Landrum, Kathleen N. Moore, Katherine M. Moxley, E.D. Thomas
Publikováno v:
Gynecologic Oncology. 144:193-199
Objectives Surgery is a cornerstone for patients with gynecologic malignancies. Surgical site infections (SSI) remain a source of post-operative morbidity. Consequences range from escalated costs, delay in adjuvant therapy, and increased morbidity. O
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e58338f6835d01101d0ee710b908b49
https://doi.org/10.1016/j.ygyno.2016.11.008
https://doi.org/10.1016/j.ygyno.2016.11.008
Autor:
Maurie Markman, Holly J. Smith, Gary Johnson, Gere S. diZerega, D.S. McMeekin, Scott Weir, Michael Baltezor, Katherine F. Roby, Jo Wick, Christine B. Mackay, Holly Maulhardt, Kathleen M. Moore, Gregory A. Reed, Stephen K. Williamson, Thomas K. Schulz, Jahna C. Espinosa, Charles J. Decedue
Publikováno v:
Cancer Chemotherapy and Pharmacology. 75:1075-1087
This multicenter, open-label, dose-escalating, phase I study evaluated the safety, tolerability, pharmacokinetics and preliminary tumor response of a nanoparticulate formulation of paclitaxel (Nanotax®) administered intraperitoneally for multiple tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b7fd8abcc0658488d2a9e97da2730e1
https://doi.org/10.1007/s00280-015-2737-4
https://doi.org/10.1007/s00280-015-2737-4
Autor:
Katherine M. Moxley, Meaghan Tenney, Cara Mathews, Joan L. Walker, E. Bishop, Lisa M. Landrum, Kathleen N. Moore, Elizabeth K. Nugent, Robert S. Mannel, D.S. McMeekin
Publikováno v:
Gynecologic Oncology. 125:94-98
Objectives Controversy continues over the importance of lymph node (LN) status in treating and predicting recurrence in endometrial cancer. Several predictive models are available which use uterine factors to stratify risk groups. Our objective was t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::293fb1771313634f802ff992550ec648
https://doi.org/10.1016/j.ygyno.2011.11.049
https://doi.org/10.1016/j.ygyno.2011.11.049
Autor:
Louise A. Brinton, David G. Mutch, Patricia L. Judson, Robert S. Mannel, Nilsa C. Ramirez, Summer B. Dewdney, Paul J. Goodfellow, David M. O'Malley, D.S. McMeekin, Kathleen M. Darcy, Jingqin Luo, Sheri A. Babb, Nora T. Kizer, Shashikant Lele, Abegail A. Andaya, Amy P. Schmidt, Russell Broaddus, Shamshad Ali, Phyllis C. Huettner
Publikováno v:
Cancer Prevention Research. 5:435-443
Serous uterine cancer is not a feature of any known hereditary cancer syndrome. This study evaluated familial risk of cancers for patients with serous uterine carcinoma, focusing on Lynch syndrome malignancies. Fifty serous or mixed serous endometria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ef3631d56cff1303358ef2cc7ea6537
https://doi.org/10.1158/1940-6207.capr-11-0499
https://doi.org/10.1158/1940-6207.capr-11-0499
Autor:
Joan L. Walker, Lisa M. Landrum, D.S. McMeekin, Tashanna K.N. Myers, Kathleen N. Moore, Michael A. Gold
Publikováno v:
Gynecologic Oncology. 108:342-347
Objective. Intraperitoneal (IP) chemotherapy has a clear survival advantage in patients with advanced ovarian cancer, but the high rate of complications has discouraged widespread acceptance. The purpose of this study was to review the completion rat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c1e2a9dc23ff9516b68e42d36b59813
https://doi.org/10.1016/j.ygyno.2007.10.004
https://doi.org/10.1016/j.ygyno.2007.10.004
Publikováno v:
Gynecologic Oncology. 143:216
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b283d807955db9f8df34db295112596c
https://doi.org/10.1016/j.ygyno.2016.08.294
https://doi.org/10.1016/j.ygyno.2016.08.294
Publikováno v:
Gynecologic Oncology. 143:207
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e2dd65afe699b13d82079c1dcf9ed52
https://doi.org/10.1016/j.ygyno.2016.08.272
https://doi.org/10.1016/j.ygyno.2016.08.272
Autor:
C.C. Gunderson, M. Rowland, D.L. Wright, K.L. Andrade, R.S. Mannel, D.S. McMeekin, K.N. Moore
Publikováno v:
Gynecologic Oncology. 141:119
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca180a65bbfe29795512be2e097323e2
https://doi.org/10.1016/j.ygyno.2016.04.320
https://doi.org/10.1016/j.ygyno.2016.04.320
Publikováno v:
Gynecologic Oncology. 135:394-395
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c66f40f46bf2f284a01b7d9118ef987
https://doi.org/10.1016/j.ygyno.2014.07.040
https://doi.org/10.1016/j.ygyno.2014.07.040